DrugPatentWatch Database Preview
ALTACE Drug Patent Profile
Email this page to a colleague
Which patents cover Altace, and when can generic versions of Altace launch?
Altace is a drug marketed by King Pharms Llc and King Pfizer and is included in two NDAs.
The generic ingredient in ALTACE is ramipril. There are nineteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ramipril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Altace
A generic version of ALTACE was approved as ramipril by WATSON LABS on October 24th, 2005.
Summary for ALTACE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 26 |
| Patent Applications: | 4,238 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ALTACE |
| Drug Sales Revenues: | Drug sales revenues for ALTACE |
| What excipients (inactive ingredients) are in ALTACE? | ALTACE excipients list |
| DailyMed Link: | ALTACE at DailyMed |
Recent Clinical Trials for ALTACE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
| Ferrer Internacional S.A. | Phase 2 |
| University of Nebraska | Phase 4 |
Pharmacology for ALTACE
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ALTACE
US Patents and Regulatory Information for ALTACE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-001 | Jan 28, 1991 | AB | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-003 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-004 | Jan 28, 1991 | AB | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-002 | Jan 28, 1991 | AB | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALTACE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-003 | Jan 28, 1991 | ⤷ Try it Free | ⤷ Try it Free |
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-002 | Jan 28, 1991 | ⤷ Try it Free | ⤷ Try it Free |
| King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | ⤷ Try it Free | ⤷ Try it Free |
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-002 | Jan 28, 1991 | ⤷ Try it Free | ⤷ Try it Free |
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-004 | Jan 28, 1991 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALTACE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 0551927 | ⤷ Try it Free |
| Czechoslovakia | 247159 | ⤷ Try it Free |
| South Korea | 840002354 | ⤷ Try it Free |
| Kenya | 3845 | ⤷ Try it Free |
| European Patent Office | 0158927 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ALTACE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0265685 | 99C0001 | Belgium | ⤷ Try it Free | PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919 |
| 0050800 | 96C0028 | Belgium | ⤷ Try it Free | PRODUCT NAME: PORFIMERE SODIQUE; NAT. REGISTRATION NO/DATE: NL 19150 19960409; FIRST REGISTRATION: NL - RVG 16652 19940411 |
| 0265685 | C980030 | Netherlands | ⤷ Try it Free | PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919 |
| 0265685 | SPC/GB98/047 | United Kingdom | ⤷ Try it Free | PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825 |
| 0079022 | SPC/GB93/145 | United Kingdom | ⤷ Try it Free | SPC/GB93/145, EXPIRES: 20040109 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
